The mini-course DIGITAL HEALTH TECHNOLOGY – Digital Transition & Intelligent Medical Devices will be launched in March 2026 at University of Rome Tor Vergata. The initiative is promoted by Rome Technopole in collaboration with Confindustria Dispositivi Medici, reflecting a coordinated effort to strengthen advanced training in a field undergoing rapid technological and organizational transformation. The programme will be delivered in a hybrid format combining on-site participation with synchronous online access, and will culminate in a project activity based on real industrial case studies provided by partner companies.

The course responds to structural changes currently reshaping the medical device sector. Digital transition is redefining the design, deployment, and evaluation of healthcare technologies through the integration of advanced sensing systems, connected and wearable platforms, biomedical digital twin modelling, artificial intelligence for assisted diagnosis, and enhanced traceability of implantable devices. At the same time, increasing attention is being devoted to cyber-physical security, data governance frameworks, and the conditions required for effective clinical adoption. These technological developments are closely linked to evolving approaches to industrial valorisation and assessment, particularly those grounded in Health Technology Assessment methodologies that examine clinical, organizational, and economic impact.

Within this context, the programme is conceived as an advanced and strongly applied educational pathway aimed at supporting the development of next-generation smart and interconnected medical technologies. Teaching activities will involve contributions from academic researchers, industry specialists, and regulatory experts, ensuring an interdisciplinary perspective that reflects the complexity of contemporary innovation ecosystems. The final design laboratory will require participants to develop feasibility studies that integrate technical, clinical, organizational, and economic dimensions, thereby fostering a comprehensive approach to innovation assessment and implementation.

The course is open to master’s students, doctoral candidates, early-career researchers, research and development professionals, regulatory affairs specialists, and representatives of public institutions engaged in healthcare innovation and governance. Participation in theoretical lectures is available to all registered attendees, while admission to the project component is limited to a selected group of participants.

The programme will begin on 5 March 2026. Registration is free of charge. Further information and enrolment are available here.